Clesrovimab (Enflonsia)
New indication (Respiratory Syncytial Virus Vaccines). The wording is on the EMA page.
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
New indication (Respiratory Syncytial Virus Vaccines). The wording is on the EMA page.
Enflonsia is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season.Enflonsia should be used in accordance with official recommendations.
To prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season